Effectiveness of Tofacitinib in Systemic Sclerosis

NCT06044844 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Efficacy of Tofacitinib in the Systemic Sclerosis

Interventions

DRUG: Tofacitinib

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Collaborators

[object Object]